Teva Launches 'It's Not OK - It's TD' National Television Advertising Campaign to Increase Awareness of Tardive Dyskinesia and AUSTEDO® (deutetrabenazine) tablets
2021 Teva Respiratory, LLC. CIQ-41277 03/2021 Support for You and Your Patients Teva Support Solutions ® provides comprehensive access and affordability support for you and your patients Teva Support Solutions® 1-844-838-2211 $0 Medication costs ...
A Guide to the Prescription and Service Request Form
Cost support for patients prescribed CINQAIR® (reslizumab) Injection
CSRWire - Teva Highlights Key Milestones Achieved in the 2017 Social Impact Report
Cinqair (reslizumab) Injection for treatment of Severe Asthma and an Eosinophilic Phenotype - Clinical Trials Arena
Shared Solutions® Support Program
Teva
CINQAIR® (reslizumab) Injection - Savings and Support
A Guide to the PRESCRIPTION AND SERVICE REQUEST FORM FOR CINQAIR® (reslizumab) Injection
A program supporting CINQAIR® (reslizumab) Injection patients
Pages - Support Home
CINQAIR® (reslizumab) Injection - Savings and Support
Teva Pharmaceuticals (@TevaUSA) / Twitter
Patient Support Program for AUSTEDO® | Teva's Shared Solutions®
Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | Business Wire
A program supporting CINQAIR® (reslizumab) Injection patients
CINQAIR® (reslizumab) Injection - Savings and Support
Teva Canada (@TevaCanadaLtd) / Twitter
Access and Affordability Support
Teva's Shared Solutions®: Financial Assistance and Adherence Support